News Overview

2014-07-31
Probiodrug Presents Pre-clinical and Clinical Findings of PQ912, a QC-Inhibitor for Alzheimer’s Disease

HALLE/SAALE, Germany, July 31, 2014 – Probiodrug AG (Probiodrug) announced today that Dr. Stephan Schilling, an expert consultant to the Company, will give an invited presentation at the upcoming Gordon Research Conference: Medicinal Chemistry, The Leading Edge of Drug Discovery. Dr. Schilling was h … more

2014-07-10
Probiodrug Presents Development Overview of PQ912, Probiodrug’s QC-Inhibitor for Alzheimer’s Disease

HALLE/SAALE, Germany, July 10, 2014 – Probiodrug AG (Probiodrug) announced that Prof. Hans-Ulrich Demuth, co-founder and consultant to the company, will give a talk detailing clinical development of PQ912 at the upcoming Alzheimer’s Association International Conference in Copenhagen, Denmark. The pr … more

2014-06-19
Probiodrug to Present at Annual BIO International Convention

HALLE/SAALE, Germany, June 19, 2014 – Probiodrug AG (Probiodrug), today announced that Dr. Hendrik Liebers, Probiodrug’s chief financial officer, will present a corporate update at the annual BIO International Convention, being held from the 23rd to the 26th of June 2014. Dr. Lieber’s presentati … more

2014-06-02
Probiodrug to Present at 2014 Asia Biotech Invest Conference

HALLE/SAALE, Germany, June 2, 2014 – Probiodrug AG (Probiodrug), today announced that the Company will participate in the second annual Asia Biotech Invest conference, to be held at the Sheraton Hotel & Towers in Hong Kong. The presentation, given by Dr Konrad Glund, Probiodrug’s chief executive … more

2014-05-19
Probiodrug to Present at Annual BioEquity Europe Conference

HALLE/SAALE, Germany, May 19, 2014 – Probiodrug AG (Probiodrug), today announced that Dr. Hendrik Liebers, chief financial officer of Probiodrug, will be presenting a corporate update at the annual BioEquity Europe conference, being held 21–22 May 2014. Dr. Liebers’ presentation will take place at 4 … more